Oligonucleotide & Nucleic Acid Xchange - Brussels - 2024

- New Modalities
- Drug Discovery
- Manufacturing
- Drug Delivery & Formulation
15:45 16:15

1-2-1 Meetings / Networking Break
- New Modalities
- Drug Discovery
- Manufacturing
- Drug Delivery & Formulation
17:20 18:20

Evening Drinks Reception
New Modalities
- New Modalities
16:20 17:20

RNA oligonucleotide as a novel replacement and improvement over in vitro transcribed mRNA for personalized cancer vaccines.

The need to increase the number of neoantigens in certain personalized cancer vaccines Advantages an ...

Christophe Van Huffel, CSO & Co-Founder - OncoRNA SA
Drug Delivery & Formulation
- Drug Delivery & Formulation
09:05 10:05

Designing targeted nanoparticles with imaging capabilities to monitor and enhance oligonucleotide delivery to sub-cellular compartments

What are the latest advancements in nanoparticle engineering for targeted oligonucleotide delivery t ...

Ashiqul Haque, Technical Lead Vaccine Development - Univercells
- New Modalities
- Drug Discovery
- Manufacturing
- Drug Delivery & Formulation
15:10 15:40

Keynote Presentation: XNA-Hub: The first worldwide experimentally-calibrated in-silico platform to model and investigate natural and non-natural nucleic acids

XNA-hub serves as a comprehensive global database and molecular modeling platform aimed at streamlin ...

Vito Genna, Director of North America - Nostrum Biodiscovery
- New Modalities
- Drug Discovery
- Manufacturing
- Drug Delivery & Formulation
15:00 15:10

Afternoon Refreshments
- New Modalities
- Drug Discovery
- Manufacturing
- Drug Delivery & Formulation
14:30 15:00

1-2-1 Meetings / Networking Break
- New Modalities
- Drug Discovery
- Manufacturing
- Drug Delivery & Formulation
14:00 14:30

1-2-1 Meetings / Networking Break
- New Modalities
- Drug Discovery
- Manufacturing
- Drug Delivery & Formulation
13:25 13:55

Spotlight Presentation: What Are Your Expectations of a Drug Substance Oligonucleotide Contract Manufacturer?

Trishul Shah, Director Business Development, Head of Sales North America - PolyPeptide
- New Modalities
- Drug Discovery
- Manufacturing
- Drug Delivery & Formulation
12:25 13:25

Networking Lunch
Manufacturing
- Manufacturing
11:25 12:25

Current challenges for drug substance CDMOs in the Oligonucleotide space

Trishul Shah, Director Business Development, Head of Sales North America - PolyPeptide
New Modalities
- New Modalities
11:25 12:25

Manufacturing topic: Manufacturing n-of-1 batches – helping 1 patient at a time?

Jeremy Little, Director of Custom Oligonucleotides - ChemGenes
- New Modalities
- Drug Discovery
- Manufacturing
- Drug Delivery & Formulation
11:15 11:25

Morning Refreshments
- New Modalities
- Drug Discovery
- Manufacturing
- Drug Delivery & Formulation
10:45 11:15

1-2-1 Meetings / Networking Break
- New Modalities
- Drug Discovery
- Manufacturing
- Drug Delivery & Formulation
10:10 10:40

1-2-1 Meetings / Networking Break
Drug Delivery & Formulation
- Drug Delivery & Formulation
16:20 17:20

Opimizing RNA vaccine delivery systems to maximize global reach and lifecycle management efficiency

Learnings from the pandemic and post-pandemic regarding the global reach of RNA vaccines Potential c ...

Ebru Dogruol, VP Global Strategy Lead - Adult Vaccines Portfolio - Pfizer
New Modalities
- New Modalities
09:05 10:05

How to improve the duration of effect and safety for mRNA therapeutics and vaccines using novel tools and modalities?

How can the duration of effect for mRNA therapeutics be increased using modifications, sequence desi ...

Ahmet C. Berkyurek, CEO & Co-founder - Cambridge Medixine
- New Modalities
- Drug Discovery
- Manufacturing
- Drug Delivery & Formulation
08:30 09:00

Opening Address & Keynote Presentation: The oligo market trend and its growth. Supporting the supply chain with cost-effective and reliable solutions for the manufacture of the future drug candidates by solid phase synthesis

Solid support for large-scale oligonucleotide production plays a crucial role in determining both th ...

Alessandra Basso, Global Sales and Marketing Director Life Science - SunResin
- New Modalities
- Drug Discovery
- Manufacturing
- Drug Delivery & Formulation
08:00 08:30

Registration